Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|October 29, 2025
Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trialJohannes Mischlinger, Klara Pechmann, Jacob Werner, et al.
Plos Neglected Tropical Diseases|March 14, 2024
Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infectionsLuzia Veletzky, Kirsten Alexandra Eberhardt, Jennifer Hergeth, et al.
Plos Neglected Tropical Diseases|March 3, 2026
The underestimated burden of placental schistosomiasis in endemic regions: Findings from a cross-sectional, diagnostic proof-of-concept study on placental schistosomiasis in GabonSaskia Dede Davi, Dearie Glory Okwu, Yabo Josiane Honkpehedji, et al.
Plos Neglected Tropical Diseases|August 28, 2023
Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trialRella Zoleko-Manego, Ruth Kreuzmair, Luzia Veletzky, et al.
The Lancet. Infectious Diseases|January 15, 2024
Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trialRaquel González, Tacilta Nhampossa, Ghyslain Mombo-Ngoma, et al.
Open Forum Infectious Diseases|August 6, 2025
Comparative Analysis of Initial Full Blood Count Parameters in Adults Infected With <i>Plasmodium falciparum</i> for Classification of Disease Severity and Previous Exposure Across Endemic (Gabon) and Nonendemic (Germany) SettingsCäcilie von Wedel, Lars Christian Matthies, Clemens Dierks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in GabonGhyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, et al.
Nature Medicine|May 15, 2026
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trialCyril Erameh, Kevin Okwaraeke, Christine Kleist, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2026
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIVLinda Stöger, Johannes Mischlinger, Tacilta Nhampossa, et al.
The Lancet. Microbe|January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and GhanaJean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
Pageof 6